Infliximab (Remicade) Lyophilized Powder from Japan
Infliximab (Remicade) is a chimeric monoclonal antibody against TNF-alpha, used for treating psoriasis and ulcerative colitis. It is presented as a lyophilized powder in measured doses for retail sale, qualifying under tariff item 3002.15.00 as an immunological product. This biotech-derived product directly regulates immunological processes.
Duty Rate — Japan → Canada
0%
Import Tips
• Ensure the lyophilized powder is in retail packaging with measured doses
• Provide reconstitution instructions and batch records for customs
• Check if a Notice of Compliance is required from Health Canada